
Bharat Biotech starts phase III trials for Covaxin; will it be world’s cheapest vaccine?
Bharat Biotech on Monday announced the commencement of phase III trials of the COVID-19 vaccine, Covaxin. It is the largest clinical trial conducted for a COVID-19 vaccine in India.
The phase III trials will involve 26,000 volunteers across 25 centres in India, being conducted in partnership with ICMR. This is India’s first phase 3 efficacy study for a COVID-19 vaccine, and the largest phase III efficacy trial ever conducted in India. The trial has been registered with ICMR and approved by the Drugs Controller General of India.
The third trial may be completed by early 2021. The most important thing is that India works on an affordable biotech vaccine, so it is expected that the Covaxin may be the cheapest vaccine in the world.
Participating volunteers who undergo vaccination in the Phase III trials, will be monitored over the next year to detect the occurrence of COVID-19 disease. Trial volunteers will receive two intramuscular injections approximately 28 days apart. Participants will be randomly assigned 1:1 to receive either two 6 microgram (mcg) injections of Covaxin or two shots of a placebo. The trial is double-blinded, such that the investigators, the participants and the company will not be aware of who is assigned to which group.
Covaxin has been evaluated in 1000 subjects in phase I and II clinical trials, with promising safety and immunogenicity data. Volunteers who wish to participate in this trial have to be adults over 18 years of age and it is still an investigational product.
About Post Author
The India Wire Team
Related
More Stories
Covishield &Covaxin prices slashed to Rs.225 from Rs.1200 and Rs.600
Vaccine makers Serum Institute of India and Bharat Biotech have reduced the price of coronavirus vaccines Covishield and Covaxin to...
23lac blessings saved 96% lung damaged mother of twin toddlers at Vadodara.
This is not just another Covid Survival story, but this is story of a movement which connected unknown people with...
Ayurveda Facts: Giloy is also known for anti ageing properties.
It’s time again to find a wave of peace in natural medicine to heal yourself. Based on many studies, Ayurveda...
Times Group Chairperson Indu Jain passed away at 84.
Times Group chairperson Indu Jain died on Thursday due to Covid-related complications, company sources said. She was 84. Hailing her...
Breaking: Dr KK Aggarwal no more; Padma Shree Awardee succumbs to COVID
After a lengthy battle with COVID-19, Dr KK Aggarwal succumbed to the virus on Monday midnight. A familiar and comforting...
Rajeev Satav passed away due to post covid complications.
Rajeev Satav began his electoral career as a block panchayat member in 2002 and went on to become both Lok...
Average Rating